Kensey Nash gets FDA clearance for Meso BioMatrix

05/26/2010 | American City Business Journals

Kensey Nash said it received FDA clearance for Meso BioMatrix, a porcine-based mesothelium extracellular matrix used to strengthen weak soft tissues, for example in hernia repair, reconstructive surgery and other forms of general surgery. The company is considering developing partnerships for the product in several markets, including urogynecology and wound care.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care